Ultragenyx Pharmaceutical Inc
LSE:0LIF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ultragenyx Pharmaceutical Inc
LSE:0LIF
|
US |
|
C
|
Capita PLC
OTC:CTAGY
|
UK |
|
DFS Furniture PLC
LSE:DFS
|
UK |
|
C
|
Commerce Bancshares Inc
F:CB5
|
US |
|
O
|
OSI Systems Inc
XMUN:OS2
|
US |
|
TUI AG
OTC:TUIFF
|
DE |
|
Phoenix Plus Corp
OTC:PXPC
|
MY |
|
C
|
Capita PLC
DUS:CTAA
|
UK |
|
F
|
Fiverr International Ltd
F:11V
|
IL |
Wall St Price Targets
0LIF Price Targets Summary
Ultragenyx Pharmaceutical Inc
According to Wall Street analysts, the average 1-year price target for 0LIF is 53.19 USD with a low forecast of 25.85 USD and a high forecast of 103.18 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0LIF's stock price target?
Price Target
53.19
USD
According to Wall Street analysts, the average 1-year price target for 0LIF is 53.19 USD with a low forecast of 25.85 USD and a high forecast of 103.18 USD.
What is the Revenue forecast for Ultragenyx Pharmaceutical Inc?
Projected CAGR
23%
The compound annual growth rate for Revenue over the next 3 years is 23%.
What is the Gross Profit forecast for Ultragenyx Pharmaceutical Inc?
Projected CAGR
18%
The compound annual growth rate for Gross Profit over the next 3 years is 18%.
